News
AstraZeneca Takes Steps Towards Ovarian Cancer Survival
Only about half of women infected with ovarian cancer survive five years after diagnosis. AstraZeneca is partnering with a group of doctors and a...
News
Present Status of US On COVID-19 Vaccines For KIDS Under 5
After the US Food and Drug Administration postponed essential steps toward legalising COVID-19 vaccinations for children under the age of five by a month,...
News
NHS Approves Game-Changing Drug For Blood Cancer Patients
Thanks to a deal reached by NHS England, a targeted new medicine for a rare and severe form of lung cancer will be accessible...
News
Peli BioThermal Hires New Director of Sales in the Americas
Patrick McGrath brings more than 20 years of cold chain industry experience to the role Peli BioThermal, the life science industry’s cold chain partner...
News
Pfizer BioNTech Seek FDA Nod For Fourth COVID-19 Senior Dos
Pfizer and BioNTech announced Tuesday that they have filed an application to the US Food and Drug Administration for urgent use permission of an...
Press Releases
Nutcracker Therapeutics Raises $167 Million in Series C Financing to Advance its mRNA Therapeutics and First-of-its-Kind Biochip-based Manufacturing Platform
Nutcracker Therapeutics, Inc., a biotech company developing RNA therapeutics using its proprietary biochip-based manufacturing platform, announced it has raised $167 million in Series C...
News
Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments
Biogen Inc. announced that the companies have amended their existing collaboration agreement on aducanumab, which is commercialized in the United States as ADUHELM. Effective...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read